High-Throughput Screening Market to Reach $12,922.7 million in 2035, Growing at 6.1% CAGR

High-throughput screening market valued at $7,200.6 million in 2025 and is projected to reach $12,922.7 million by 2035, growing at a CAGR of 6.1% during the forecast period (2026-2035). The market encompasses automated and miniaturized screening technologies used to rapidly evaluate large libraries of chemical compounds, biological molecules, and genetic materials for drug discovery and life sciences research applications. The market is witnessing sustained global expansion supported by rising R&D expenditure and growth in biopharmaceutical innovation. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), U.S. biopharmaceutical companies invested over $100 billion annually in research and development in recent years, underscoring strong demand for advanced screening platforms.  Additionally, the National Institutes of Health (NIH) allocates more than $45 billion annually toward biomedical research, supporting academic and translational research initiatives that rely heavily on high-throughput screening technologies. The growing burden of chronic diseases and oncology indications is further accelerating screening activities. The World Health Organization (WHO) reports that cancer remains a leading cause of death globally, driving sustained investment in early-stage compound screening and biomarker identification.

Browse the full report description of “High-Throughput Screening Market Size, Share & Trends Analysis Report by Product and Services (Consumables, Instruments, Services, and Software), by Technology (Cell-Based Assays, Lab-on-a-Chip Technology, and Label-Free Technology), and by Application (Drug Discovery, Biochemical Screening, Life Sciences Research, and Other) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/high-throughput-screening-market

Advancements in automation, robotics, artificial intelligence integration, and high-content imaging are enhancing screening speed, accuracy, and scalability. Increasing collaborations between pharmaceutical companies, contract research organizations (CROs), and academic institutions are also strengthening the HTS ecosystem globally.

Key Statistics: High-Throughput Screening at a Glance

• Biopharmaceutical R&D spending exceeds $100 billion annually, as reported by the Pharmaceutical Research and Manufacturers of America, supporting large-scale screening activities.
• The National Institutes of Health funds over $45 billion annually in biomedical research, reinforcing adoption of automated screening platforms.

Key Innovators Driving High-Throughput Screening Transformation

The key players in the high-throughput screening market Agilent Technologies, Inc., Danaher Corporation, Merck KGaA, Revvity, Inc., Thermo Fisher Scientific Inc, among others.

• In June 2025, Thermo Fisher Scientific introduced the Thermo Scientific Orbitrap Astral Zoom and Orbitrap Excedion Pro mass spectrometers at ASMS 2025. The systems are developed to provide higher speed and sensitivity for proteomics and biopharmaceutical research, supporting high-throughput omics workflows used in screening and target identification.
• In August 2025, Revvity, Inc. launched pHSense reagents for high-throughput internalization studies in drug discovery. The plate-based approach combines pH-sensitive dye chemistry with time-resolved fluorescence detection, enabling scalable screening of GPCRs and antibody–drug conjugates within automated laboratory workflows.
• In September 2025, Revvity, Inc. released Living Image Synergy AI software for multimodal preclinical imaging analysis. The platform incorporates AI-based tools to automate segmentation and quantification processes, reducing manual analysis steps and supporting higher-throughput research activities.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product and Services
  • By Technology
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Agilent Technologies, Inc., Danaher Corporation, Merck KGaA, Revvity, Inc., Thermo Fisher Scientific Inc, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global High-Throughput Screening Market Report Segment

By Product and Services

• Consumables
• Instruments
• Services
• Software

By Technology

• Cell-Based Assays
• Lab-on-a-Chip Technology
• Label-Free Technology

By Application

• Drug Discovery
• Biochemical Screening
• Life Sciences Research
• Other

Global High-Throughput Screening Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/high-throughput-screening-market